Exploiting the overexpression of folate receptor α (FOLR1) in many cancer types, folate-caged degraders have been designed,193 envisioned to be transported preferentially into cancer cells, where intracellular hydrolase catalysis activates the degrader by release of the folate caging group. Here, FOLR1 is linked to cancer.